Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Sell
36,000
-39,000
-52% -$2.6M 0.12% 73
2026
Q1
$4.71M Buy
75,000
+28,000
+60% +$1.95M 0.27% 56
2025
Q4
$3.12M Buy
+47,000
New +$3.04M 0.18% 63

Other funds holding DXCM

DNCA Finance's DXCM Position: Q2 2026 in Review

DNCA Finance reduced its DexCom (DXCM) stake by 52% in Q2 2026, selling an estimated $2.6M and leaving 36,000 shares worth $2.42M. The position accounts for 0.12% of the portfolio, ranked #73.

DNCA Finance first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.71M in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • DNCA Finance held 36,000 shares of DexCom worth $2.42M as of Q2 2026.
  • DNCA Finance sold 39,000 DexCom shares in Q2 2026, an estimated $2.6M.
  • DexCom made up 0.12% of DNCA Finance's portfolio in Q2 2026, its #73 holding.
  • DNCA Finance first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • DNCA Finance's DexCom position peaked at $4.71M in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on DNCA Finance's 13F filing for Q2 2026, filed 13 Aug 2026.